A detailed history of Putnam Investments LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Putnam Investments LLC holds 1,510,259 shares of LLY stock, worth $1.24 Billion. This represents 1.21% of its overall portfolio holdings.

Number of Shares
1,510,259
Previous 1,628,961 7.29%
Holding current value
$1.24 Billion
Previous $875 Million 0.62%
% of portfolio
1.21%
Previous 1.37%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $62.3 Million - $73.5 Million
-118,702 Reduced 7.29%
1,510,259 $880 Million
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $79.6 Million - $110 Million
-183,036 Reduced 10.1%
1,628,961 $875 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $911,222 - $1.22 Million
2,598 Added 0.14%
1,811,997 $850 Million
Q1 2023

May 22, 2023

BUY
$310.63 - $364.82 $6.17 Million - $7.25 Million
19,865 Added 1.11%
1,809,399 $621 Million
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $11.7 Million - $13.7 Million
36,498 Added 2.08%
1,789,534 $655 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $134 Million - $153 Million
451,536 Added 34.69%
1,753,036 $567 Million
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $9.5 Million - $11.2 Million
34,089 Added 2.69%
1,301,500 $422 Million
Q1 2022

May 16, 2022

SELL
$234.69 - $291.66 $85.1 Million - $106 Million
-362,532 Reduced 22.24%
1,267,411 $363 Million
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $90.7 Million - $113 Million
-403,443 Reduced 19.84%
1,629,943 $450 Million
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $469 Million - $577 Million
-2,115,124 Reduced 50.99%
2,033,386 $470 Million
Q2 2021

Aug 16, 2021

SELL
$180.55 - $233.54 $50.6 Million - $65.4 Million
-280,133 Reduced 6.33%
4,148,510 $952 Million
Q1 2021

May 17, 2021

SELL
$164.32 - $212.72 $23.1 Million - $29.9 Million
-140,367 Reduced 3.07%
4,428,643 $827 Million
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $55.7 Million - $73.7 Million
426,791 Added 10.3%
4,569,010 $771 Million
Q3 2020

Nov 16, 2020

BUY
$146.22 - $169.13 $111 Million - $128 Million
757,407 Added 22.38%
4,142,219 $613 Million
Q2 2020

Aug 14, 2020

BUY
$136.42 - $164.18 $175 Million - $210 Million
1,281,767 Added 60.95%
3,384,812 $556 Million
Q1 2020

May 15, 2020

SELL
$119.05 - $147.35 $4.86 Million - $6.02 Million
-40,830 Reduced 1.9%
2,103,045 $292 Million
Q4 2019

Feb 14, 2020

SELL
$106.92 - $132.43 $24.1 Million - $29.8 Million
-225,126 Reduced 9.5%
2,143,875 $282 Million
Q3 2019

Nov 14, 2019

SELL
$106.79 - $116.16 $23.3 Million - $25.4 Million
-218,331 Reduced 8.44%
2,369,001 $265 Million
Q2 2019

Aug 14, 2019

BUY
$110.79 - $129.32 $20.4 Million - $23.9 Million
184,437 Added 7.68%
2,587,332 $287 Million
Q1 2019

May 15, 2019

SELL
$111.31 - $131.02 $21.8 Million - $25.7 Million
-196,066 Reduced 7.54%
2,402,895 $312 Million
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $50.6 Million - $56.6 Million
477,348 Added 22.5%
2,598,961 $301 Million
Q3 2018

Nov 14, 2018

BUY
$85.86 - $107.31 $4.08 Million - $5.11 Million
47,576 Added 2.29%
2,121,613 $228 Million
Q2 2018

Aug 14, 2018

SELL
$75.7 - $86.88 $261,543 - $300,170
-3,455 Reduced 0.17%
2,074,037 $177 Million
Q1 2018

May 15, 2018

BUY
$74.21 - $87.6 $3.36 Million - $3.96 Million
45,215 Added 2.22%
2,077,492 $161 Million
Q4 2017

Feb 14, 2018

SELL
$81.94 - $87.89 $54.9 Million - $58.9 Million
-670,443 Reduced 24.81%
2,032,277 $172 Million
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $208 Million - $231 Million
2,702,720
2,702,720 $231 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $778B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Putnam Investments LLC Portfolio

Follow Putnam Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.